We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
+0.55%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$48B
AUM Growth
-$1.59B
(-3.2%)
Cap. Flow
-$1.46B
Cap. Flow
% of AUM
-3.05%
Top 10 Holdings %
Top 10 Hldgs %
24.06%
Holding
1,904
New
84
Increased
534
Reduced
502
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$60.6M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$50.8M |
| 3 |
Mastercard
MA
|
+$43.1M |
| 4 |
Analog Devices
ADI
|
+$40.3M |
| 5 |
Broadcom
AVGO
|
+$40.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$92.3M |
| 2 |
NVIDIA
NVDA
|
+$92.1M |
| 3 |
Eli Lilly
LLY
|
+$80.8M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$74.2M |
| 5 |
Microsoft
MSFT
|
+$69.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.14% |
| 2 | Financials | 15.08% |
| 3 | Healthcare | 14.69% |
| 4 | Consumer Discretionary | 11.11% |
| 5 | Communication Services | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
CME Group
CME
$92.2B
| $169M | 0.35% |
872,941
+27,761
| +3% | +$5.62M |
|
77
Enterprise Products Partners
EPD
$83.8B
| $166M | 0.35% |
7,692,492
-1,805,037
| -19% | -$41M |
|
78
Duke Energy
DUK
$102B
| $163M | 0.34% |
1,672,969
-127,523
| -7% | -$13.2M |
|
|
79
Broadcom
AVGO
$1.82T
| $163M | 0.34% |
3,359,510
+823,880
| +32% | +$40.1M |
|
80
Mondelez International
MDLZ
$77.7B
| $162M | 0.34% |
2,786,022
-3,708
| -0.1% | -$231K |
|
|
81
Eli Lilly
LLY
$1.07T
| $157M | 0.33% |
677,739
-327,396
| -33% | -$80.8M |
|
82
Cigna
CI
$76.6B
| $156M | 0.33% |
781,174
-220,755
| -22% | -$48M |
|
|
SCHW
83
Charles Schwab
SCHW
$177B
| $152M | 0.32% |
2,085,080
+280,826
| +16% | +$20.1M |
|
84
Bristol-Myers Squibb
BMY
$127B
| $150M | 0.31% |
2,543,383
-33,428
| -1% | -$2.2M |
|
85
Verizon
VZ
$194B
| $149M | 0.31% |
2,757,692
-739,361
| -21% | -$40.9M |
|
86
Reinsurance Group of America
RGA
$15.7B
| $148M | 0.31% |
1,329,037
-97,018
| -7% | -$11.1M |
|
87
Medtronic
MDT
$107B
| $140M | 0.29% |
1,119,599
+45,208
| +4% | +$5.85M |
|
|
88
State Street SPDR S&P 500 ETF Trust
SPY
$778B
| $140M | 0.29% |
326,988
+115,103
| +54% | +$50.8M |
|
89
Gilead Sciences
GILD
$161B
| $139M | 0.29% |
1,987,029
-132,383
| -6% | -$9.3M |
|
90
IBM
IBM
$202B
| $136M | 0.28% |
1,022,637
-99,199
| -9% | -$13.3M |
|
91
State Street Blackstone Senior Loan ETF
SRLN
$5.31B
| $135M | 0.28% |
2,930,000
| – | – |
|
92
Humana
HUM
$46.7B
| $131M | 0.27% |
335,911
+32,203
| +11% | +$13.7M |
|
93
Fastenal
FAST
$54B
| $131M | 0.27% |
5,064,690
-1,697,406
| -25% | -$46.1M |
|
94
Target
TGT
$62.1B
| $130M | 0.27% |
566,287
-65,242
| -10% | -$16.3M |
|
95
Wabtec
WAB
$51.1B
| $129M | 0.27% |
1,497,099
-177,077
| -11% | -$15.2M |
|
96
EPAM Systems
EPAM
$4.69B
| $128M | 0.27% |
224,756
-27,397
| -11% | -$16.1M |
|
97
CoStar Group
CSGP
$11.3B
| $128M | 0.27% |
1,487,082
-241,908
| -14% | -$20.9M |
|
98
Monolithic Power Systems
MPWR
$65.5B
| $127M | 0.27% |
262,892
+23,895
| +10% | +$10.9M |
|
99
CVS Health
CVS
$137B
| $125M | 0.26% |
1,476,827
+16,252
| +1% | +$1.36M |
|
100
Republic Services
RSG
$66.7B
| $124M | 0.26% |
1,034,490
+43,477
| +4% | +$5.2M |
|
Similar funds
SCP
Ensign Peak Advisors's Q3 2021 Portfolio in Review
As of Q3 2021, Ensign Peak Advisors held 1,904 positions worth $48B, down 3.2% from $49.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Ensign Peak Advisors withdrew a net $1.46B in Q3 2021, closing 55 positions and reducing 502 holdings. Its most notable exit was Root, an estimated $29.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Ensign Peak Advisors opened a new position in State Street SPDR S&P Biotech ETF worth $37.7M.
- Ensign Peak Advisors's largest Q3 2021 buy was State Street SPDR S&P Biotech ETF: 300,000 shares worth $37.7M.
- Ensign Peak Advisors added most to AbbVie in Q3 2021, an estimated $60.6M increase.
- Ensign Peak Advisors's biggest Q3 2021 reduction was Walt Disney, cutting an estimated $92.3M.
- Ensign Peak Advisors fully exited Root in Q3 2021, selling an estimated $29.6M.
- Ensign Peak Advisors's ten largest holdings make up 24% of its $48B portfolio in Q3 2021.
- Ensign Peak Advisors opened 84 new positions and closed 55 in Q3 2021.
- Ensign Peak Advisors's portfolio value fell 3.2% quarter-over-quarter to $48B.
Based on Ensign Peak Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.